US President Joe Biden announced on Thursday that the US has agreed to buy 10 million treatment courses of Pfizer’s new – and not yet authorized – COVID- 19 starting later this year and ending in 2022. 19 treatment pill.
In a statement on the White House website, the president said his administration is taking steps to ensure that these treatments are easily accessible and free of charge once they are approved by the Food and Drug Administration and the Centers for Disease Control and Prevention.
In a release posted on its website on Thursday, Pfizer said the US government will pay approximately $5.29 billion for the pill, which will be marketed as Paxlovid, pending authorization.
When the pill was announced earlier this month, Pfizer said the latest clinical trials showed an 89% reduction in the risk of hospitalizations and deaths related to COVID-19.
Pfizer was the second US drugmaker to develop an oral treatment for COVID-19. In October, Merck introduced its COVID-19 pill, which clinical studies have shown to provide a 50% reduction in hospitalizations and deaths due to COVID-19.
The FDA is due to rule on the Merck Pill later this month. Britain’s drug regulator has already approved this pill.
The White House announced last month that the US has already made arrangements to purchase 1.7 million doses of the Merck pill, with the option to obtain more if necessary.
In his statement, Biden said the treatment could prove to be another important tool in the US arsenal that will speed the way out of the pandemic. But he insisted that vaccines are the strongest tool and urged everyone who has not to be vaccinated.
Some of the information for this report was provided by The Associated Press, Reuters and Agence France-Presse.